Abstract
Cell inflammation and death are closely linked processes contributing to endothelial
dysfunction, which plays a critical role in atherogenesis. Activation of the NLRP3
inflammasome causes pyroptosis, the Gasdermin D (GSDMD)-mediated inflammatory cell
death. The non-canonical NF-κB pathway has been implicated in inflammation; however,
its role in NLRP3 inflammasome-mediated endothelial dysfunction has not been investigated.
This study investigated a role for the non-canonical NF-κB pathway in regulating endothelial
pyroptosis as it relates to atherogenesis. Immunohistochemistry indicated inflammasome
activation in the endothelial cells (EC) of human atherosclerotic arteries. Flow cytometry
and Western blot analysis revealed that oxidized low-density lipoprotein (oxLDL) activated
the NLRP3 inflammasome, concomitant with the activation of non-canonical NF-κB in
primary human aortic EC. Interference of NF-κB inducing kinase (NIK), the key regulator
of the non-canonical pathway, significantly attenuated oxLDL- or LPS/ATP-induced NLRP3
inflammasome activation, pyroptosis, IL-1β, and IL-18 secretion. In contrast, overexpression
of NIK exacerbated these responses. Chromatin immunoprecipitation revealed that activation
of the non-canonical NF-κB pathway upregulated the transcription factor IRF-1 through
RelB/p52 binding to its promoter region at -782/-770. In addition to the known target
CASP1, RNA sequencing further identified GSDMD as a target gene of IRF-1. IRF-1 but not RelB/p52 interacted with the GSDMD promoter at -526/-515 and the CASP1 promoter at -11/10 to promote the expression and CASP1-mediated activation of GSDMD. Consistent with the observations in cultured endothelium,
endothelial-specific deficiency of NIK or IRF-1 attenuated atherosclerosis in high-fat
diet-fed Apoe-null mice. These data demonstrate that the non-canonical NF-κB pathway contributes
to NLRP3 inflammasome-mediated endothelial pyroptosis and the development of atherosclerosis
through GSDMD activation in a manner dependent on IRF-1. Further investigation may
facilitate the identification of specific therapeutic targets for atherosclerotic
heart diseases.
Abbreviations:
ChIP (chromatin immunoprecipitation assay), DAMP (danger-associated molecular patterns), ELISA (enzyme linked immunosorbent assay), GSDMD (gasdermin D), HAEC (human aortic endothelial cell), IRF-1 (interferon regulatory factor 1), MAEC (murine aortic endothelial cell), NF-κB (nuclear factor-kappa B), NIK (NF-kB inducing kinase), NLRP3 (NOD-like receptor P3), oxLDL (oxidized low-density lipoprotein), PAMP (pathogen-associated molecular patterns), RHD (Relhomology domain), TAD (transcription activation domain)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Translational ResearchAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Endothelial cell dysfunction and the pathobiology of atherosclerosis.Circ Res. 2016; 118: 620-636
- Atherosclerosis—an inflammatory disease.N Engl J Med. 1999; 340: 115-126
- Role of pyroptosis in cardiovascular diseases and its therapeutic implications.Int J Biol Sci. 2019; 15: 1345-1357
- Pyroptosis: gasdermin-mediated programmed necrotic cell death.Trends Biochem Sci. 2017; 42: 245-254
- NLRP3 inflammasome and the IL-1 pathway in atherosclerosis.Circ Res. 2018; 122: 1722-1740
- NLRP3 inflammasome: its regulation and involvement in atherosclerosis.J Cell Physiol. 2018; 233: 2116-2132
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.Nature. 2010; 464: 1357-1361
- NLRP3 inflammasome expression and activation in human atherosclerosis.J Am Heart Assoc. 2016; 5: 1-11
- Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients.Heart Vessels. 2016; 31: 1218-1229
- NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice-brief report.Arterioscler Thromb Vasc Biol. 2017; 37: 1457-1461
- The non-canonical NF-kappaB pathway in immunity and inflammation.Nat Rev Immunol. 2017; 17: 545-558
- MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.Nature. 1997; 385: 540-544
- BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.Nat Immunol. 2002; 3: 958-965
- CD40 regulates the processing of NF-kappaB2 p100 to p52.EMBO J. 2002; 21: 5375-5385
- The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.Immunity. 2002; 17: 525-535
- Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.PLoS One. 2012; 7: e29371
- Reduction of atherosclerosis in mice by inhibition of CD40 signalling.Nature. 1998; 394: 200-203
- Deficiency of endothelial CD40 induces a stable plaque phenotype and limits inflammatory cell recruitment to atherosclerotic lesions in mice.Thromb Haemost. 2021; 121: 1530-1540
- Complement membrane attack complexes activate noncanonical NF-kappaB by forming an Akt+ NIK+ signalosome on Rab5+ endosomes.Proc Natl Acad Sci U S A. 2015; 112: 9686-9691
- Noncanonical NF-kappaB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.Atherosclerosis. 2018; 270: 33-41
- Caspase-1 inflammasome activation mediates homocysteine-induced Pyrop-apoptosis in endothelial cells.Circ Res. 2016; 118: 1525-1539
- Liver NF-kappaB-inducing kinase promotes liver steatosis and glucose counterregulation in male mice with obesity.Endocrinology. 2017; 158: 1207-1216
- Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration.Circulation. 2011; 124: 48-57
- IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium.J Mol Cell Cardiol. 2020; 140: 30-41
- Interferon regulatory factor-1 mediates alveolar macrophage pyroptosis during LPS-induced acute lung injury in mice.Shock. 2016; 46: 329-338
- IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9.Nature. 2006; 440: 949-953
- Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK.Mol Immunol. 2008; 45: 1926-1934
- An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes.Nature. 1995; 376: 596-599
- Gasdermins and their role in immunity and inflammation.J Exp Med. 2019; 216: 2453-2465
- Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway.Arterioscler Thromb Vasc Biol. 2015; 35: 804-816
- Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease.Arterioscler Thromb Vasc Biol. 2011; 31: 2781-2786
- Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.Cell Death Dis. 2018; 9: 171
- Endothelial Foxp1 suppresses atherosclerosis via modulation of Nlrp3 inflammasome activation.Circ Res. 2019; 125: 590-605
- Nuclear factor-kappaB activation as a pathological mechanism of lipid metabolism and atherosclerosis.Adv Clin Chem. 2015; 70: 1-30
- Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases.Immunol Rev. 2017; 277: 61-75
- Complement membrane attack complexes assemble NLRP3 inflammasomes triggering IL-1 activation of IFN-gamma-primed human endothelium.Circ Res. 2019; 124: 1747-1759
- The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.Br J Pharmacol. 2015; 172: 5457-5476
- Absence of interferon regulatory factor 1 protects against atherosclerosis in apolipoprotein E-deficient mice.Theranostics. 2019; 9: 4688-4703
- Caspase-1 initiates apoptosis in the absence of gasdermin D.Nat Commun. 2019; 10: 2091
- IFN regulatory factor 1 mediates macrophage pyroptosis induced by oxidized low-density lipoprotein in patients with acute coronary syndrome.Mediators Inflamm. 2019; 20192917128
- The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection.Nat Immunol. 2015; 16: 467-475
- Human IRGM induces autophagy to eliminate intracellular mycobacteria.Science. 2006; 313: 1438-1441
- The Crohn's disease risk factor IRGM limits NLRP3 inflammasome activation by impeding its assembly and by mediating its selective autophagy.Mol Cell. 2019; 73 (e427): 429-445
- GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I/R injury.Circ Res. 2021; 129: 383-396
- IRF2 transcriptionally induces GSDMD expression for pyroptosis.Sci Signal. 2019; 12: 1-12
- Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes.Nat Commun. 2015; 6: 8761
Article info
Publication history
Published online: November 12, 2022
Accepted:
November 1,
2022
Received in revised form:
October 7,
2022
Received:
August 13,
2022
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2022 Elsevier Inc. All rights reserved.
